After more than 25 years working with biotech innovators, I’ve learned that the real value of a patent family lies in the inventive scope where your science, legal strategy, and innovation truly meet . That intersection is what I call the patent sweet spot . So, what exactly is the sweet spot? It’s the range of claim scope that matches the working examples in your application — broad enough to protect what matters commercially, but grounded enough in data to avoid overreach

Innovation, collaboration, and thoughtful IP strategy, that’s what built Invitrogen’s success. And it’s still what drives the best...

Why Your Biotech Patent Keeps Getting Rejected, and What to Do About It. If your biotech patent application keeps getting rejected, it’s...

Struggling to get tough biotech patents allowed? A reactive, traditional "strategy" often fails. Try these 4 proactive, effective...

Biotech products and processes evolve over time. This can cause a misalignment between your issued/pending patent claims, and your...

Biotech innovation is regularly faced with a thicket of prior art that applicants must navigate during patent prosecution. Examiners at...

SUMMARY: Biologic candidates evolve during clinical trials - so should your patents. Updated filings before public trial disclosures...

Working examples are an important part of a biotech patent application, especially because this is considered an unpredictable art in...

Like many technology areas, the vast majority of, if not all, biotech/biopharma inventions build on prior art teachings. Thus, a major...

Common misconceptions about patent rights: In my decades of counseling life sciences companies, I have found that many inventors and...

A day to celebrate biotech! 🥳 Congrats to Vertex and CRISPR Therapeutics on FDA approval of CASGEVY • 1st product that uses gene editing...